[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Instructions for UsePatient Labeling for Human Prescription...[ Price : $8.95]
FDA approves a Provepharm NDA for Bludigo (indigotindisulfonate sodium), a diagnostic dye indicated for use as a visualization aid...[ Price : $8.95]
The House Energy and Commerce Committee leadership calls on the Senate to urgently reauthorize FDAs user fee programs.[ Price : $8.95]
Hospira recalls one lot of propofol injectable emulsion due to the presence of a visible particulate in a single retained vial fro...[ Price : $8.95]
FDA solicits comments on software functions excluded from the medical device definition by the 21st Century Cures Act.[ Price : $8.95]
FDA publishes a guidance on the content and format of patient instructions for use documents for prescription drugs and biologics.[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Genentechs Enspryng (satral...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for GlaxoSmithKlines Blenrep (b...